Caxton Associates (New York)’s AGNC Investment AGNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-127,792
Closed -$1.34M 486
2024
Q3
$1.34M Buy
+127,792
New +$1.3M 0.05% 194
2023
Q2
Sell
-56,248
Closed -$567K 478
2023
Q1
$567K Sell
56,248
-95,662
-63% -$1.04M 0.09% 234
2022
Q4
$1.57M Buy
151,910
+49,624
+49% +$453K 0.1% 70
2022
Q3
$861K Buy
102,286
+22,648
+28% +$266K 0.11% 145
2022
Q2
$882K Sell
79,638
-31,694
-28% -$376K 0.09% 147
2022
Q1
$1.46M Buy
111,332
+27,271
+32% +$381K 0.12% 57
2021
Q4
$1.26M Buy
84,061
+25,113
+43% +$398K 0.13% 82
2021
Q3
$930K Buy
+58,948
New +$955K 0.1% 108
2021
Q2
Sell
-43,689
Closed -$732K 462
2021
Q1
$732K Buy
+43,689
New +$706K 0.07% 105
2020
Q3
Sell
-33,223
Closed -$429K 300
2020
Q2
$429K Buy
+33,223
New +$417K 0.04% 169
2017
Q4
Sell
-30,900
Closed -$670K 334
2017
Q3
$670K Buy
30,900
+200
+0.7% +$4.27K 0.02% 245
2017
Q2
$654K Sell
30,700
-500
-2% -$10.4K 0.03% 238
2017
Q1
$621K Buy
+31,200
New +$601K ﹤0.01% 198

Other funds holding AGNC

Caxton Associates (New York)'s AGNC Position: Q4 2024 in Review

Caxton Associates (New York) sold out of AGNC Investment (AGNC) in Q4 2024, closing a stake of 127,792 shares — an estimated $1.34M sold.

Caxton Associates (New York) first reported a position in AGNC in Q1 2017 and held it in 13 quarters. The position peaked at $1.57M in Q4 2022. 551 funds tracked by Wall St. Rank hold AGNC as of Q4 2024.

  • Caxton Associates (New York) reported no remaining AGNC Investment position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 127,792 AGNC Investment shares in Q4 2024, an estimated $1.34M.
  • Caxton Associates (New York) first reported a position in AGNC Investment in Q1 2017 and held it in 13 quarters.
  • Caxton Associates (New York)'s AGNC Investment position peaked at $1.57M in Q4 2022.
  • 551 funds tracked by Wall St. Rank held AGNC Investment as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.